Watanabe Kimio

ワタナベキミオ | Watanabe Kimio

Affiliation and department：

Research field (1)： Nephrology

Research theme for competitive and other funds (5)：

2022 - 2025 Study on the pathophysiological mechanism of sarcopenia in CKD patients and examination of the effects of HIF-PH inhibitors
2016 - 2020 Development of innovative peritoneal dialysis system employing molecular hydrogen
2015 - 2017 Chronic kidney disease (CKD) and Cognitive impairment: Possible mechanisms of Cerebro-renal interaction
2012 - 2015 Study of the significance of intermittent hypoxia on risk management of chronic kidney disease
2012 - 2015 Chronic kidney disease (CKD) and Cognitive impairment: Possible mechanisms of Cerebro-renal interaction

Papers (37)：

Kimio Watanabe, Emiko Sato, Eikan Mishima, Shinobu Moriya, Takuma, Skabe, Atsuya Sato, Momoko Fujiwara, Takuya Fujimaru, Yugo Ito, et al. Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study. International Journal of Molecular Sciences. 2023. 24. 16. 12752
Hideaki Kuno, Takuya Fujimaru, Nozomi Kadota, Kasumi Konishi, Momoko Sekiguchi, Kimio Watanabe, Yugo Ito, Masahiko Nagahama, Fumika Taki, Toru Hifumi, et al. Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. CEN case reports. 2023
Kimio Watanabe, Emiko Sato, Eikan Mishima, Mariko Miyazaki, Tetsuhiro Tanaka. What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances. Int J Mol Sci. 2022. 24. 1. 570
Shinobu Moriya, Shun Nishizawa, Yayoi Tsuchihashi, Yoshihiro Inoue, Kimio Watanabe, Yugo Ito, Hassu Kin, Masaaki Nakayama. Impact on change in serum beta 2 microglobulin by combination therapy of peritoneal dialysis and hemodialysis: a 12-month preliminary observational study. Renal Replacement Therapy. 2022. 8. 1
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Asami Takeda, Shunya Uchida, Tatsuo Tsukamoto, Kazuhiko Tsuruya, Yasuhiro Akai, et al. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study. Sci Rep. 2022. 12. 1. 9782

ｍore...

MISC (21)：

岡田浩一, 安田宜成, 旭浩一, 伊藤孝史, 要伸也, 神田英一郎, 菅野義彦, 四方賢一, 柴垣有吾, 土谷健, et al. エビデンスに基づくCKD診療ガイドライン2018. 日本腎臓学会誌. 2018. 60. 8. 1037-1193
岡田浩一, 安田宜成, 旭浩一, 伊藤孝史, 要伸也, 神田英一郎, 菅野義彦, 四方賢一, 柴垣有吾, 土谷健, et al. エビデンスに基づくCKD診療ガイドライン2018. 日本腎臓学会誌. 2018. 60. 8. 1037-1193
中山昌明, 渡邉公雄, 宮崎真理子. 【尿酸、XORと内皮細胞障害】脳血管障害と尿酸. 高尿酸血症と痛風. 2018. 26. 1. 78-83
朱万君, 渡邉公雄, 山本多恵, 宮崎真理子, 伊藤貞嘉, 中山昌明. CKDラットにおいて分子状水素(H2)は2.5%中性ブドウ糖腹膜透析(PD)液による腹膜中皮細胞(PMC)傷害を抑制する. 日本透析医学会雑誌. 2017. 50. Suppl.1. 562-562
山本多恵, 宮崎真理子, 渡邉公雄, 山田元, 佐藤博, 中山昌明, 伊藤貞嘉. 高齢者CKDにおける血圧と利尿薬使用の臨床予後との関連艮陵CKD研究. 日本腎臓学会誌. 2017. 59. 3. 265-265

ｍore...

Work history (7)：

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page